Form 4: Saba Capital Management Increases Stake in Destra Multi-Alternative Fund
SEC Form 4
Saba Capital Management, a significant shareholder in Destra Multi-Alternative Fund, has increased its holdings through recent purchases of common stock.
Summary
- Saba Capital Management, L.P., along with Boaz Weinstein, has filed a Form 4 detailing changes in beneficial ownership of Destra Multi-Alternative Fund (DMA).
- On July 16, 2024, Saba Capital acquired 9,079 shares of common stock at a price of $8.4 per share.
- On July 17, 2024, they acquired an additional 77,666 shares at $8.39 per share.
- Following these transactions, Saba Capital's indirect beneficial ownership totals 1,682,757 shares.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a routine disclosure of stock purchases. The increased stake could be seen as mildly positive, but it's not a major event.
Positives
- Increased investment by a major shareholder could signal confidence in the fund's prospects.
Industry Context
Hedge funds like Saba Capital often take activist positions in closed-end funds like Destra Multi-Alternative Fund, seeking to unlock value through various strategies such as pressing for fund restructuring or tender offers.
Stakeholder Impact
- Shareholders may view the increased stake positively, potentially leading to a slight increase in share price.
Key Dates
| Date | Description |
|---|---|
| 07/16/2024 | Saba Capital acquired 9,079 shares of DMA at $8.4 per share. |
| 07/17/2024 | Saba Capital acquired 77,666 shares of DMA at $8.39 per share. |
| 07/18/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.